Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Meyskens

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
Lancet (London, England)|August 2, 1980
Topical vitamin-A-acid therapy for cutaneous metastatic melanomaN Levine, F L Meyskens
Journal of the National Cancer Institute|December 5, 1990
Beta-carotene didn't prevent cancer: what's up doc?H Garewal, F L Meyskens
The American Journal of Clinical Nutrition|December 1, 1995
Prevention of cervical intraepithelial neoplasia and cervical cancerF L Meyskens, A Manetta
Arizona Medicine|December 1, 1977
Endocrine therapy of breast cancer: a new look. The role of receptor assaysA Eisenberg, F L Meyskens
Seminars in Oncology|September 1, 1983
Vitamin A: a potential inhibitor of human cancerT Kummet, F L Meyskens
Cancer Research|November 1, 1982
Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanomaS P Thomson, F L Meyskens
Cancer Treatment Reports|March 1, 1982
AMSA therapy for children with lymphoblastic malignancyJ J Hutter, F L Meyskens
Journal of the American College of Nutrition|August 1, 1988
Vitamin A derivatives in the prevention and treatment of human cancerS M Lippman, F L Meyskens
The New England Journal of Medicine|April 13, 1978
Terminal transferase: its evolving roleF L Meyskens, S E Jones
British Journal of Cancer|January 1, 1981
Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin, and nerve growth factorF L Meyskens, S E Salmon
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
Lancet (London, England)|August 2, 1980
Topical vitamin-A-acid therapy for cutaneous metastatic melanomaN Levine, F L Meyskens
Journal of the National Cancer Institute|December 5, 1990
Beta-carotene didn't prevent cancer: what's up doc?H Garewal, F L Meyskens
The American Journal of Clinical Nutrition|December 1, 1995
Prevention of cervical intraepithelial neoplasia and cervical cancerF L Meyskens, A Manetta
Arizona Medicine|December 1, 1977
Endocrine therapy of breast cancer: a new look. The role of receptor assaysA Eisenberg, F L Meyskens
Seminars in Oncology|September 1, 1983
Vitamin A: a potential inhibitor of human cancerT Kummet, F L Meyskens
Cancer Research|November 1, 1982
Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanomaS P Thomson, F L Meyskens
Cancer Treatment Reports|March 1, 1982
AMSA therapy for children with lymphoblastic malignancyJ J Hutter, F L Meyskens
Journal of the American College of Nutrition|August 1, 1988
Vitamin A derivatives in the prevention and treatment of human cancerS M Lippman, F L Meyskens
The New England Journal of Medicine|April 13, 1978
Terminal transferase: its evolving roleF L Meyskens, S E Jones
British Journal of Cancer|January 1, 1981
Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin, and nerve growth factorF L Meyskens, S E Salmon
Pageof 23